+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Treatment of community acquired pneumonia with doxycycline in a predominantly African American population



Treatment of community acquired pneumonia with doxycycline in a predominantly African American population








Accession: 022028623

Download citation: RISBibTeXText


Related references

Doxycycline for treatment of community-acquired pneumonia. Clinical Infectious Diseases 35(5): 632; Author Reply 632-3, 2002

Treatment for community acquired pneumonia: more support for doxycycline. Archives of Internal Medicine 159(15): 1814-1815, 1999

Doxycycline vs. levofloxacin in the treatment of community-acquired pneumonia. Journal of Clinical Pharmacy and Therapeutics 35(2): 195-200, 2010

Doxycycline vs. macrolides in combination therapy for treatment of community-acquired pneumonia. Clinical Microbiology and Infection 18(4): E71, 2012

How much evidence do we have to recommend oral doxycycline for empirical treatment of community-acquired pneumonia?. Clinical Infectious Diseases 38(3): 459-460, 2004

Doxycycline versus Macrolides in Combination therapy for treatment of Community-Acquired Pneumonia. 2012

Effectiveness of ceftriaxone plus doxycycline in the treatment of patients hospitalized with community-acquired pneumonia. Journal of Hospital Medicine 1(1): 7-12, 2006

Rapid defervescence after doxycycline treatment of macrolide-resistant Mycoplasma pneumoniae-associated community-acquired pneumonia in children. Pediatric Infectious Disease Journal 32(12): 1396-1399, 2013

Pneumonia severity, comorbidity and 1-year mortality in predominantly older adults with community-acquired pneumonia: a cohort study. Bmc Infectious Diseases 15: 2, 2015

Doxycycline for community-acquired pneumonia. Clinical Infectious Diseases 37(6): 870, 2003

Doxycycline and community-acquired pneumonia. American Family Physician 57(3): 426-427, 1998

Disparity of risk-adjusted inpatient outcomes among African American and white patients hospitalized with community-acquired pneumonia. Population Health Management 15(4): 201-206, 2012

Efficacy and safety of ten day moxifloxacin 400 mg once daily in the treatment of patients with community-acquired pneumonia. Community Acquired Pneumonia Study Group. Respiratory Medicine 94(2): 97-105, 2000

Doxycycline or moxifloxacin for the management of community-acquired pneumonia in the UK?. International Journal of Antimicrobial Agents 32(2): 101-105, 2008

A controlled trial of a critical pathway for treatment of community-acquired pneumonia. CAPITAL Study Investigators. Community-Acquired Pneumonia Intervention Trial Assessing Levofloxacin. JAMA 283(6): 749-755, 2000